NeuroMetrix, Inc. (NASDAQ:NURO – Get Free Report) saw a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 2,500 shares, an increase of 78.6% from the February 13th total of 1,400 shares. Approximately 0.2% of the company’s stock are sold short. Based on an average daily volume of 19,700 shares, the short-interest ratio is currently 0.1 days.
Wall Street Analysts Forecast Growth
Separately, StockNews.com initiated coverage on NeuroMetrix in a research report on Wednesday. They set a “sell” rating for the company.
View Our Latest Stock Analysis on NeuroMetrix
Institutional Trading of NeuroMetrix
NeuroMetrix Stock Performance
NASDAQ:NURO remained flat at $4.37 during mid-day trading on Friday. 1,074 shares of the company traded hands, compared to its average volume of 13,926. The stock has a market cap of $8.97 million, a P/E ratio of -0.95 and a beta of 2.15. NeuroMetrix has a 1-year low of $2.66 and a 1-year high of $4.73. The company has a 50 day moving average price of $4.26 and a two-hundred day moving average price of $4.10.
About NeuroMetrix
NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.
Featured Stories
- Five stocks we like better than NeuroMetrix
- Investing In Preferred Stock vs. Common Stock
- How to Build the Ultimate Everything ETF Portfolio
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- What is the Shanghai Stock Exchange Composite Index?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for NeuroMetrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeuroMetrix and related companies with MarketBeat.com's FREE daily email newsletter.